![M. Glenn Richard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
M. Glenn Richard
Private Equity Investor bei ARDIAN Investment UK Ltd.
Profil
Glenn Richard - Managing Director
After gaining initial experience in international financing in industry, Glenn Richard joined Ardian in 2000.
Education: ESF Cergy-Pontoise
Aktive Positionen von M. Glenn Richard
Unternehmen | Position | Beginn |
---|---|---|
ARDIAN Investment UK Ltd.
![]() ARDIAN Investment UK Ltd. Investment ManagersFinance ARDIAN Investment UK Ltd. operates as an investment manager and advisor to private equity funds. It offers its investors a diversified choice of funds covering the full range of asset classes, including Fund of Funds and Direct Funds. The firm is a subsidiary of Ardian SA. The company was founded in 1996 and is headquartered in London, the United Kingdom. | Private Equity Investor | 01.01.2000 |
Ehemalige bekannte Positionen von M. Glenn Richard
Unternehmen | Position | Ende |
---|---|---|
ERYTech Pharma SA
![]() ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Direktor/Vorstandsmitglied | 18.07.2007 |
ScreenCell SA
![]() ScreenCell SA Miscellaneous Commercial ServicesCommercial Services ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France. | Direktor/Vorstandsmitglied | - |
Cytheris SA
![]() Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | Direktor/Vorstandsmitglied | - |
Ausbildung von M. Glenn Richard
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Cytheris SA
![]() Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | Health Technology |
ERYTech Pharma SA
![]() ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
ScreenCell SA
![]() ScreenCell SA Miscellaneous Commercial ServicesCommercial Services ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France. | Commercial Services |
ARDIAN Investment UK Ltd.
![]() ARDIAN Investment UK Ltd. Investment ManagersFinance ARDIAN Investment UK Ltd. operates as an investment manager and advisor to private equity funds. It offers its investors a diversified choice of funds covering the full range of asset classes, including Fund of Funds and Direct Funds. The firm is a subsidiary of Ardian SA. The company was founded in 1996 and is headquartered in London, the United Kingdom. | Finance |
Université Cergy-Pontoise | Consumer Services |